HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Gastrointestinal cancers, which include cancers of the stomach, liver, pancreas, esophagus, and colorectal regions, are among the most challenging cancers to treat due to their often late-stage diagnoses. Advances in imaging technologies, such as endoscopy and CT scans, along with the discovery of specific biomarkers, have significantly improved early detection rates. Treatment strategies for gastrointestinal cancers typically involve a combination of surgery, chemotherapy, and radiation therapy, with personalized approaches tailored to the patient's cancer type and stage. Additionally, the development of targeted therapies, including those focused on specific molecular pathways, and the rise of immunotherapy, have brought new hope to patients. Ongoing research into the genetic and environmental factors contributing to these cancers aims to unlock more effective treatments, ultimately improving survival outcomes and reducing the burden of side effects.
